EB is a 54-year-old man of European decent with diet controlled diabetes mellitus, HTN, dyslipidemia, and gastroesophageal reflux disease (GERD). He is a current smoker. His current medications include lisinopril 20 mg/day, amlodipine 10 mg/day, pravastatin 40 mg/day, and omeprazole 20 mg/day. Fasting laboratory results show glucose 109 mg/dL, TC 197 mg/dL, LDL-C 128 mg/dL, HDL-C 37 mg/dL, and TG 166 mg/dL. His non-HDL is 160 mg/dL. His systolic blood pressure is 130 mmHg and the PCE (pooled Cohort Equation) estimates his 10 year risk of ASCVD to be 26.8%. • Based on the currently available guidelines, textbook and patient specific criteria given in the case, what is your plan for this patient in regard to 'statin' therapy? Be sure to include: o Lifestyle modifications o Drug, dose, rationale and monitoring (including what should be done if there are complaints of SAMS) o Patient education

EB is a 54-year-old man of European decent with diet controlled diabetes mellitus, HTN, dyslipidemia, and gastroesophageal reflux disease (GERD). He is a current smoker. His current medications include lisinopril 20 mg/day, amlodipine 10 mg/day, pravastatin 40 mg/day, and omeprazole 20 mg/day. Fasting laboratory results show glucose 109 mg/dL, TC 197 mg/dL, LDL-C 128 mg/dL, HDL-C 37 mg/dL, and TG 166 mg/dL. His non-HDL is 160 mg/dL. His systolic blood pressure is 130 mmHg and the PCE (pooled Cohort Equation) estimates his 10 year risk of ASCVD to be 26.8%.

• Based on the currently available guidelines, textbook and patient specific criteria given in the case, what is your plan for this patient in regard to 'statin' therapy? Be sure to include:
  • Lifestyle modifications
  • Drug, dose, rationale and monitoring (including what should be done if there are complaints of SAMS)
  • Patient education

Order this paper